Clinically Relevant Interpretation of Genotype and Relationship to Plasma Drug Concentrations for Resistance to Saquinavir-Ritonavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.48.12.4687-4692.2004
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2004
Authors
Publisher
American Society for Microbiology